TrialDiabetes, obesity & metabolism2025

De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: A single-centre, open-label randomised trial (TRANSITION-T2D).

Paloma Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.